Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Montana Wildhack who wrote (7778)	10/4/2001 1:25:33 AM
From: Cal Gary	Read Replies (1) \| Respond to of 14101

President's message updated at www.dimethaid.com FYI, perhaps old news by this late hour. Written confirmation that there's much preparatory work being done for the Canadian market. I hope there's really more here than counting the chicks before they hatch. I suspect the investment in marketing material, doctor's kits and internal sales should shorten time to market when approval is in hand. The payoff is relatively quicker revenue. Otherwise should this gambit goes amiss then its money down the toilet. To date, we have received net proceeds of approximately $5.7 million to support the scale up of our manufacturing facility in order to supply PENNSAID® to a number of markets and for the preparation of its North American and European launch. In Canada, in anticipation of the approval of PENNSAID®, our sales and marketing departments have spent the past months finalizing our marketing plans, completing our advertising campaign, preparing training manuals and physician detail aids and hiring the requisite staff. We intend to market and distribute PENNSAID® in Canada utilizing our internal resources, which will complete another corporate milestone towards our goal of being a fully integrated pharmaceutical company. I agree its not a funny matter when good folks suffer and live with chronic pain. My humour, being along the lines similiar to your EU politics comment, but mine was directed at Allan Rock and HC's sponsored pet/weed project also hurt DMX investors, too. Not a funny matter either. n this case EU politics between Britain and the continent countries hurt DMX investors. I don't see that it being a topical arthritis cream or a wild man from Borneo would have made much difference in the outcome. .